Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Press release 2020-06-25

Xspray – Virtual Capital Markets Day today at 14.00 CET

Press release 2020-06-18

Invitation to virtual Capital Markets Day with Xspray on June 25 at 14.00-15.30 CET

Regulatory press release 2020-05-29

Xspray Pharma initiates pivotal registration studies with HyNap-Dasa for the market approval application in the United States

Regulatory press release 2020-05-14

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

Press release 2020-05-14

Xspray Pharma publishes Interim report Q1, January – March 2020

Regulatory press release 2020-04-15

Xspray Pharma provides an update on how the Covid-19 pandemic affects the company’s planned clinical studies

Regulatory press release 2020-04-14

XSpray: Notice of annual general meeting of Xspray Pharma AB (publ)

Press release 2020-03-27

Trading in Xspray Pharma’s shares commences today on Nasdaq Stockholm

Press release 2020-03-26

Bulletin from the extraordinary general meeting of Xspray Pharma AB (publ)

Press release 2020-03-26

The conditions for Xspray Pharma’s listing on Nasdaq Stockholm have been fulfilled

Show more

IR contact

Jacob Nyberg, IRO

+46 (0)70 767 08 83

info@xspray.com

Subscribe

  • This field is for validation purposes and should be left unchanged.
  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com